New Report Available: Peru Pharmaceuticals & Healthcare Report Q4 2014
Although per capita medicine spending in Peru is among the lowest in Latin America, pharmaceutical companies can generate rapid sales growth in the country due to the lack of a mandatory medicine pricing system in the country. More stringent quality control, a relatively weak domestic pharmaceutical industry, the ongoing liberalisation of bilateral trade agreements and the healthcare reform as well as Peru's investor-friendly business environment will further benefit foreign companies.
View full press release